Skip to main content
Erschienen in: Endocrine 2/2016

07.11.2015 | Original Article

Vitamin D-binding protein and free vitamin D concentrations in acromegaly

verfasst von: Alev Eroglu Altinova, Cigdem Ozkan, Mujde Akturk, Ozlem Gulbahar, Muhittin Yalcin, Nuri Cakir, Fusun Balos Toruner

Erschienen in: Endocrine | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Free 25-hydroxyvitamin D [25(OH)D] is suggested to be important in the determination of vitamin D deficiency, since vitamin D-binding protein (VDBP) may affect total 25(OH)D levels. There are no data about free 25(OH)D concentrations in acromegaly. We aimed to investigate serum VDBP and total and free 25(OH)D levels in patients with acromegaly in comparison with control subjects. We recruited 54 patients with acromegaly and 32 control subjects who were similar according to age, gender, and body mass index. Serum VDBP levels were found to be increased in patients with acromegaly compared to control subjects [90.35 (72.45–111.10) vs. 69.52 (63.89–80.13) mg/l, p = 0.001]. There was statistically no significant difference in serum total 25(OH)D levels between the patients with acromegaly and control subjects [18.63 (13.35–27.73) vs. 22.51 (19.20–28.96) ng/ml, p = 0.05]. Free 25(OH)D levels were significantly decreased in patients with acromegaly compared to control subjects [14.55 (10.45–21.45) vs. 17.75 (15.30–23.75) pg/ml, p = 0.03]. Free 25(OH)D levels correlated positively with total 25(OH)D (p = 0.0001) and HDL cholesterol (p = 0.04) and negatively with fasting blood glucose (p = 0.04). Our findings indicate that VDBP is increased and free 25(OH)D is decreased in acromegaly, while there is no significant alteration in total 25(OH)D.
Literatur
1.
Zurück zum Zitat L. Lieben, G. Carmeliet, R. Masuyama, Calcemic actions of vitamin D: effects on the intestine, kidney and bone. Best Pract. Res. Clin. Endocrinol. Metab. 25, 561–572 (2011)CrossRefPubMed L. Lieben, G. Carmeliet, R. Masuyama, Calcemic actions of vitamin D: effects on the intestine, kidney and bone. Best Pract. Res. Clin. Endocrinol. Metab. 25, 561–572 (2011)CrossRefPubMed
2.
Zurück zum Zitat A.R. Menezes, M.C. Lamb, C.J. Lavie, J.J. DiNicolantonio, Vitamin D and atherosclerosis. Curr. Opin. Cardiol. 29, 571–577 (2014)CrossRefPubMed A.R. Menezes, M.C. Lamb, C.J. Lavie, J.J. DiNicolantonio, Vitamin D and atherosclerosis. Curr. Opin. Cardiol. 29, 571–577 (2014)CrossRefPubMed
3.
Zurück zum Zitat Y. Song, L. Wang, A.G. Pittas, L.C. Del Gobbo, C. Zhang, J.E. Manson, F.B. Hu, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36, 1422–1428 (2013)CrossRefPubMedPubMedCentral Y. Song, L. Wang, A.G. Pittas, L.C. Del Gobbo, C. Zhang, J.E. Manson, F.B. Hu, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36, 1422–1428 (2013)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat J.P. Forman, G.C. Curhan, E.N. Taylor, Plasma 25-hydroxy vitamin D levels and risk of incident hypertension among young women. Hypertension 52, 828–832 (2008)CrossRefPubMedPubMedCentral J.P. Forman, G.C. Curhan, E.N. Taylor, Plasma 25-hydroxy vitamin D levels and risk of incident hypertension among young women. Hypertension 52, 828–832 (2008)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat C. Berg, S. Petersenn, H. Lahner, B.L. Herrmann, M. Buchfelder, M. Droste, G.K. Stalla, C.J. Strasburger, U. Roggenbuck, N. Lehmann, S. Moebus, K.H. Jockel, S. Mohlenkamp, R. Erbel, B. Saller, K. Mann, Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J. Clin. Endocrinol. Metab. 95, 3648–3656 (2010)CrossRefPubMed C. Berg, S. Petersenn, H. Lahner, B.L. Herrmann, M. Buchfelder, M. Droste, G.K. Stalla, C.J. Strasburger, U. Roggenbuck, N. Lehmann, S. Moebus, K.H. Jockel, S. Mohlenkamp, R. Erbel, B. Saller, K. Mann, Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J. Clin. Endocrinol. Metab. 95, 3648–3656 (2010)CrossRefPubMed
6.
Zurück zum Zitat G. Mazziotti, E. Biagioli, F. Maffezzoni, M. Spinello, V. Serra, R. Maroldi, I. Floriani, A. Giustina, Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 100, 384–394 (2015)CrossRefPubMed G. Mazziotti, E. Biagioli, F. Maffezzoni, M. Spinello, V. Serra, R. Maroldi, I. Floriani, A. Giustina, Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 100, 384–394 (2015)CrossRefPubMed
7.
Zurück zum Zitat S. Takamoto, H. Tsuchiya, T. Onishi, S. Morimoto, S. Imanaka, S. Mori, Y. Seino, T. Uozumi, Y. Kumahara, Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J. Clin. Endocrinol. Metab. 61, 7–11 (1985)CrossRefPubMed S. Takamoto, H. Tsuchiya, T. Onishi, S. Morimoto, S. Imanaka, S. Mori, Y. Seino, T. Uozumi, Y. Kumahara, Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J. Clin. Endocrinol. Metab. 61, 7–11 (1985)CrossRefPubMed
8.
Zurück zum Zitat S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 20, 1837–1844 (2005)CrossRefPubMed S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 20, 1837–1844 (2005)CrossRefPubMed
9.
Zurück zum Zitat P. Kamenicky, A. Blanchard, C. Gauci, S. Salenave, A. Letierce, M. Lombes, S. Brailly-Tabard, M. Azizi, D. Prie, J.C. Souberbielle, P. Chanson, Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J. Clin. Endocrinol. Metab. 97, 2124–2133 (2012)CrossRefPubMed P. Kamenicky, A. Blanchard, C. Gauci, S. Salenave, A. Letierce, M. Lombes, S. Brailly-Tabard, M. Azizi, D. Prie, J.C. Souberbielle, P. Chanson, Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J. Clin. Endocrinol. Metab. 97, 2124–2133 (2012)CrossRefPubMed
10.
Zurück zum Zitat J. Halupczok-Zyla, A. Jawiarczyk-Przybylowska, M. Bolanowski, Patients with active acromegaly are at high risk of 25(OH)D deficiency. Front. Endocrinol. (Lausanne) 6, 89 (2015) J. Halupczok-Zyla, A. Jawiarczyk-Przybylowska, M. Bolanowski, Patients with active acromegaly are at high risk of 25(OH)D deficiency. Front. Endocrinol. (Lausanne) 6, 89 (2015)
11.
Zurück zum Zitat A.J. Brown, D.W. Coyne, Bioavailable vitamin D in chronic kidney disease. Kidney Int. 82, 5–7 (2012)CrossRefPubMed A.J. Brown, D.W. Coyne, Bioavailable vitamin D in chronic kidney disease. Kidney Int. 82, 5–7 (2012)CrossRefPubMed
12.
Zurück zum Zitat J.B. Schwartz, J. Lai, B. Lizaola, L. Kane, S. Markova, P. Weyland, N.A. Terrault, N. Stotland, D. Bikle, A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J. Clin. Endocrinol. Metab. 99, 1631–1637 (2014)CrossRefPubMedPubMedCentral J.B. Schwartz, J. Lai, B. Lizaola, L. Kane, S. Markova, P. Weyland, N.A. Terrault, N. Stotland, D. Bikle, A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J. Clin. Endocrinol. Metab. 99, 1631–1637 (2014)CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat D.D. Bikle, E. Gee, B. Halloran, M.A. Kowalski, E. Ryzen, J.G. Haddad, Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 63, 954–959 (1986)CrossRefPubMed D.D. Bikle, E. Gee, B. Halloran, M.A. Kowalski, E. Ryzen, J.G. Haddad, Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 63, 954–959 (1986)CrossRefPubMed
14.
Zurück zum Zitat H.Q. Ying, H.L. Sun, B.S. He, Y.Q. Pan, F. Wang, Q.W. Deng, J. Chen, X. Liu, S.K. Wang, Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer. Sci. Rep. 5, 7956 (2015)CrossRefPubMedPubMedCentral H.Q. Ying, H.L. Sun, B.S. He, Y.Q. Pan, F. Wang, Q.W. Deng, J. Chen, X. Liu, S.K. Wang, Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer. Sci. Rep. 5, 7956 (2015)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat L. Kane, K. Moore, D. Lutjohann, D. Bikle, J.B. Schwartz, Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. J. Clin. Endocrinol. Metab. 98, 4400–4409 (2013)CrossRefPubMedPubMedCentral L. Kane, K. Moore, D. Lutjohann, D. Bikle, J.B. Schwartz, Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. J. Clin. Endocrinol. Metab. 98, 4400–4409 (2013)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat P. Glendenning, G.T. Chew, C.A. Inderjeeth, M. Taranto, W.D. Fraser, Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone 56, 271–275 (2013)CrossRefPubMed P. Glendenning, G.T. Chew, C.A. Inderjeeth, M. Taranto, W.D. Fraser, Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone 56, 271–275 (2013)CrossRefPubMed
17.
Zurück zum Zitat A.P. Ashraf, C. Huisingh, J.A. Alvarez, X. Wang, B.A. Gower, Insulin resistance indices are inversely associated with vitamin D binding protein concentrations. J. Clin. Endocrinol. Metab. 99, 178–183 (2014)CrossRefPubMedPubMedCentral A.P. Ashraf, C. Huisingh, J.A. Alvarez, X. Wang, B.A. Gower, Insulin resistance indices are inversely associated with vitamin D binding protein concentrations. J. Clin. Endocrinol. Metab. 99, 178–183 (2014)CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat R.F. Chun, B.E. Peercy, E.S. Orwoll, C.M. Nielson, J.S. Adams, M. Hewison, Vitamin D and DBP: the free hormone hypothesis revisited. J. Steroid Biochem. Mol. Biol. 144, 132–137 (2014)CrossRefPubMed R.F. Chun, B.E. Peercy, E.S. Orwoll, C.M. Nielson, J.S. Adams, M. Hewison, Vitamin D and DBP: the free hormone hypothesis revisited. J. Steroid Biochem. Mol. Biol. 144, 132–137 (2014)CrossRefPubMed
19.
Zurück zum Zitat M.S. Johnsen, G. Grimnes, Y. Figenschau, P.A. Torjesen, B. Almas, R. Jorde, Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand. J. Clin. Lab. Investig. 74, 177–183 (2014)CrossRef M.S. Johnsen, G. Grimnes, Y. Figenschau, P.A. Torjesen, B. Almas, R. Jorde, Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand. J. Clin. Lab. Investig. 74, 177–183 (2014)CrossRef
20.
Zurück zum Zitat C.E. Powe, C. Ricciardi, A.H. Berg, D. Erdenesanaa, G. Collerone, E. Ankers, J. Wenger, S.A. Karumanchi, R. Thadhani, I. Bhan, Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J. Bone Miner. Res. 26, 1609–1616 (2011)CrossRefPubMedPubMedCentral C.E. Powe, C. Ricciardi, A.H. Berg, D. Erdenesanaa, G. Collerone, E. Ankers, J. Wenger, S.A. Karumanchi, R. Thadhani, I. Bhan, Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J. Bone Miner. Res. 26, 1609–1616 (2011)CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)CrossRefPubMed A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)CrossRefPubMed
22.
Zurück zum Zitat L. Katznelson, J.L. Atkinson, D.M. Cook, S.Z. Ezzat, A.H. Hamrahian, K.K. Miller, American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly–2011 update: executive summary. Endocr. Pract. 17, 636–646 (2011)CrossRefPubMed L. Katznelson, J.L. Atkinson, D.M. Cook, S.Z. Ezzat, A.H. Hamrahian, K.K. Miller, American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly–2011 update: executive summary. Endocr. Pract. 17, 636–646 (2011)CrossRefPubMed
23.
Zurück zum Zitat American Diabetes Association, Classification and diagnosis of diabetes. Diabetes Care 38, S8–S16 (2015)CrossRef American Diabetes Association, Classification and diagnosis of diabetes. Diabetes Care 38, S8–S16 (2015)CrossRef
24.
Zurück zum Zitat P.A. James, S. Oparil, B.L. Carter, W.C. Cushman, C. Dennison-Himmelfarb, J. Handler, D.T. Lackland, M.L. LeFevre, T.D. MacKenzie, O. Ogedegbe, S.C. Smith Jr, L.P. Svetkey, S.J. Taler, R.R. Townsend, J.T. Wright Jr, A.S. Narva, E. Ortiz, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520 (2014)CrossRefPubMed P.A. James, S. Oparil, B.L. Carter, W.C. Cushman, C. Dennison-Himmelfarb, J. Handler, D.T. Lackland, M.L. LeFevre, T.D. MacKenzie, O. Ogedegbe, S.C. Smith Jr, L.P. Svetkey, S.J. Taler, R.R. Townsend, J.T. Wright Jr, A.S. Narva, E. Ortiz, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520 (2014)CrossRefPubMed
25.
Zurück zum Zitat Third Report of the National Cholesterol Education Program (NCEP), Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 106, 3143–3421 (2002) Third Report of the National Cholesterol Education Program (NCEP), Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 106, 3143–3421 (2002)
26.
Zurück zum Zitat M.M. Speeckaert, R. Speeckaert, N. van Geel, J.R. Delanghe, Vitamin D binding protein: a multifunctional protein of clinical importance. Adv. Clin. Chem. 63, 1–57 (2014)CrossRefPubMed M.M. Speeckaert, R. Speeckaert, N. van Geel, J.R. Delanghe, Vitamin D binding protein: a multifunctional protein of clinical importance. Adv. Clin. Chem. 63, 1–57 (2014)CrossRefPubMed
27.
Zurück zum Zitat R.F. Chun, New perspectives on the vitamin D binding protein. Cell Biochem. Funct. 30, 445–456 (2012)CrossRefPubMed R.F. Chun, New perspectives on the vitamin D binding protein. Cell Biochem. Funct. 30, 445–456 (2012)CrossRefPubMed
28.
Zurück zum Zitat P. Yousefzadeh, S.A. Shapses, X. Wang, Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int. J. Endocrinol. 2014, 981581 (2014)CrossRefPubMedPubMedCentral P. Yousefzadeh, S.A. Shapses, X. Wang, Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int. J. Endocrinol. 2014, 981581 (2014)CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Z. Dastani, C. Berger, L. Langsetmo, L. Fu, B.Y. Wong, S. Malik, D. Goltzman, D.E. Cole, J.B. Richards, In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations. J. Bone Miner. Res. 29, 494–499 (2014)CrossRefPubMed Z. Dastani, C. Berger, L. Langsetmo, L. Fu, B.Y. Wong, S. Malik, D. Goltzman, D.E. Cole, J.B. Richards, In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations. J. Bone Miner. Res. 29, 494–499 (2014)CrossRefPubMed
30.
Zurück zum Zitat J. Aloia, M. Mikhail, R. Dhaliwal, A. Shieh, G. Usera, A. Stolberg, L. Ragolia, S. Islam, Free 25(OH)D and the vitamin D paradox in African Americans. J. Clin. Endocrinol. Metab. 100, 3356–3363 (2015)CrossRefPubMed J. Aloia, M. Mikhail, R. Dhaliwal, A. Shieh, G. Usera, A. Stolberg, L. Ragolia, S. Islam, Free 25(OH)D and the vitamin D paradox in African Americans. J. Clin. Endocrinol. Metab. 100, 3356–3363 (2015)CrossRefPubMed
31.
Zurück zum Zitat A. Vitezova, M.C. Zillikens, T.T. van Herpt, E.J. Sijbrands, A. Hofman, A.G. Uitterlinden, O.H. Franco, J.C. Kiefte-de Jong, Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study. Eur. J. Endocrinol. 172, 327–335 (2015)CrossRefPubMed A. Vitezova, M.C. Zillikens, T.T. van Herpt, E.J. Sijbrands, A. Hofman, A.G. Uitterlinden, O.H. Franco, J.C. Kiefte-de Jong, Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study. Eur. J. Endocrinol. 172, 327–335 (2015)CrossRefPubMed
32.
Zurück zum Zitat A. Tsur, B.S. Feldman, I. Feldhammer, M.B. Hoshen, G. Leibowitz, R.D. Balicer, Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care 36, 1361–1367 (2013)CrossRefPubMedPubMedCentral A. Tsur, B.S. Feldman, I. Feldhammer, M.B. Hoshen, G. Leibowitz, R.D. Balicer, Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care 36, 1361–1367 (2013)CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat N.M. van Schoor, M. Visser, S.M. Pluijm, N. Kuchuk, J.H. Smit, P. Lips, Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 42, 260–266 (2008)CrossRefPubMed N.M. van Schoor, M. Visser, S.M. Pluijm, N. Kuchuk, J.H. Smit, P. Lips, Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 42, 260–266 (2008)CrossRefPubMed
34.
Zurück zum Zitat R. Shah, A. Licata, N.M. Oyesiku, A.G. Ioachimescu, Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature. Pituitary 15(Suppl 1), S17–S22 (2012)CrossRefPubMed R. Shah, A. Licata, N.M. Oyesiku, A.G. Ioachimescu, Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature. Pituitary 15(Suppl 1), S17–S22 (2012)CrossRefPubMed
35.
Zurück zum Zitat P. Ameri, A. Giusti, M. Boschetti, G. Murialdo, F. Minuto, D. Ferone, Interactions between vitamin D and IGF-I: from physiology to clinical practice. Clin. Endocrinol. (Oxf) 79, 457–463 (2013)CrossRef P. Ameri, A. Giusti, M. Boschetti, G. Murialdo, F. Minuto, D. Ferone, Interactions between vitamin D and IGF-I: from physiology to clinical practice. Clin. Endocrinol. (Oxf) 79, 457–463 (2013)CrossRef
36.
Zurück zum Zitat A. Ajmal, A. Haghshenas, S. Attarian, M. Barake, N.A. Tritos, A. Klibanski, K.K. Miller, L.B. Nachtigall, The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary 17, 366–373 (2014)CrossRefPubMed A. Ajmal, A. Haghshenas, S. Attarian, M. Barake, N.A. Tritos, A. Klibanski, K.K. Miller, L.B. Nachtigall, The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary 17, 366–373 (2014)CrossRefPubMed
Metadaten
Titel
Vitamin D-binding protein and free vitamin D concentrations in acromegaly
verfasst von
Alev Eroglu Altinova
Cigdem Ozkan
Mujde Akturk
Ozlem Gulbahar
Muhittin Yalcin
Nuri Cakir
Fusun Balos Toruner
Publikationsdatum
07.11.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0789-1

Weitere Artikel der Ausgabe 2/2016

Endocrine 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.